March II 2025
Addressing issues such as congestive heart failure is important to providing safe care to patients with cancer.
A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers evaluated.
The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell therapies for solid tumors.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
2
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
What Stood Out at IMS 2026? Five Myeloma Experts Weigh In
5